Nanobiotix (NasdaqGS:NBTX) FY Conference September 09, 2025 09:00 AM ET Company ParticipantsAake - UnspecifiedLaurent Levy - Chief Executive OfficerBart Van Rhijn - Chief Financial and Business OfficerAakeGood morning, and thanks for joining us to have a conversation with Laurent Levy, CEO, and Bart Van Rhijn, CFO of Nanobiotix. Nanobiotix is developing a radioenhancer, NBTXR3, which is hafnium oxide nanoparticles that can be induced by radiotherapy to cause significant tumor cell death in the injected tumo ...